PlexusDx's approach treats semaglutide as one tool in a comprehensive wellness toolkit, not as a standalone solution
Semaglutide has a well-established safety profile in people with T2D and obesity, including in people aged 65 years and older, suggesting that it will be well tolerated in the evoke/evoke+ populations with early AD [15, 27, 41,42,43,44, 57, 58, 63]
Spatially resolved proteomic map shows that extracellular matrix regulates epidermal growth
Patients should: Monitor body weight regularly and report rapid or excessive weight loss Ensure adequate protein intake to preserve lean muscle mass Stay hydrated , as both medications can contribute to dehydration Consider consultation with a registered dietitian if maintaining adequate nutrition becomes difficult Monitor blood glucose if taking insulin or sulfonylureas, as reduced food intake may increase hypoglycemia risk Medication administration timing requires attention: For Rybelsus (oral semaglutide): Take on an empty stomach upon waking with no more than 4 oz of water, then wait at least 30 minutes before taking Adderall or consuming food For Adderall: Generally taken in the morning to minimize insomnia
Eating smaller, more frequent meals throughout the day can help to regulate appetite and prevent overeating